IL6 and juvenile idiopathic arthritis: This trial is a novel adaptive design study of subcutaneous IL-6 inhibition in anti-TNF refractory JIA associated uveitis which will be able to determine if further research into the use of this intervention for the treatment of anti-TNF refractory JIA-associated uveitis should be conducted.